Improved cosmesis in early breast cancer using conformal radiotherapy

Journal of Clinical Oncology

Volumn 31, Issue 36, 2013, Pages 4483-4484

  Kavanagh, Brian D ^a   Rabinovitch, Rachel ^a   Mohideen, Najeeb ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NORTHWEST COMMUNITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COSMESIS; DOSIMETRY; EARLY CANCER; EDITORIAL; ESTHETICS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MULTILEAF COLLIMATOR; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME; BREAST TUMOR; FEMALE; NOTE; BREAST NEOPLASMS;

BEAUTY; BREAST NEOPLASMS; FEMALE; HUMANS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84894419196     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.52.6442     Document Type: Editorial

References (10)

1. Mukesh MB, Barnett GC, Wilkinson JS, et al: Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31:4488-4495, 2013
2. American Society for Radiation Oncology Choosing Wisely Campaign: Five things physicians and patients should question. http://www.choosingwisely.org/ wp-content/uploads/2013/09/ASTRO-5things-List-092013.pdf
3. Pignol JP, Olivotto I, Rakovitch E, et al: A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26:2085-2092, 2008
4. Smith BD, Pan IW, Shih YC, et al: Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 103:798-809, 2011
5. Butcher L: ASTRO developing payment reform plan. Oncol Times 35:18-19, 2013
6. Bradley JD, Paulus R, Komaki R, et al: A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617. J Clin Oncol 31:458s, 2013 (suppl; abstr 7501)
7. Sheets NC, Goldin GH, Meyer AM, et al: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307:1611-1620, 2012
8. Clinicaltrials.gov: Proton therapy vs. IMRT for low or intermediate risk prostate cancer (PARTIQoL). http://clinicaltrials.gov/show/NCT01617161
9. White JR, Halberg FE, Rabinovitch R, et al: American College of Radiology appropriateness criteria on conservative surgery and radiation: Stages I and II breast carcinoma. J Am Coll Radiol 5:701-713, 2008 (Pubitemid 351749595)
10. Smith BD, Bentzen SM, Correa CR, et al: Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 81:59-68, 2011